BUSINESS REVIEW, PROSPECTS AND FUTURE PLAN

 

  Since early 2020, the outbreak of Coronavirus Disease 2019 (the “COVID-19”) has spread throughout the world. Every countries had implemented different levels of disease prevention measures, including lockdown and quarantine policies.

 

  Hong Kong suffered the fifth wave of the COVID-19 in 2022, certain prevention measures were implemented.

 

  The COVID-19 definitely impacted to Hong Kong, The People's of the Republic of China (the “PRC”) and even the global economy. The Hang Seng Index fell 15.46% per cent in 2022, and unfavourable performance of financial market in United States of America (the “US”), as a result, the Group suffered net loss for the Reporting Period.

 

  The external environment is of high relevance to the economy and financial market in Hong Kong. In term of the COVID-19 still raging across the world and the Russo-Ukrainian War, the Group expects it will continue to affect the Group’s financial performance. The Group will closely monitor the development of the external environment and continue to evaluate its impact on our business, financial position and operating results.

 

  Looking ahead to the year 2023, the Company will stay in focus to invest in trading securities, private equity funds and private enterprises with potential prospect. Our approach will keep timely and appropriate investment strategies in response to the volatile market, in order to enhance our investment portfolio and achieve net asset appreciation. The Board will pay close attention to the macro trends and keep seeking opportunities to invest in China, Hong Kong and overseas. The Company will continue to implement its risk management policy with an aim to achieve stable returns on investments for our shareholders.